167 related articles for article (PubMed ID: 24168290)
1. Sunitinib-related interstitial pneumonia after treatment with temsirolimus: a case of possible recall phenomenon.
Kushima H; Ishii H; Kadota J
Int J Urol; 2014 Apr; 21(4):420-1. PubMed ID: 24168290
[TBL] [Abstract][Full Text] [Related]
2. [A case of interstitial lung disease due to sunitinib].
Sekiguchi Z; Takizawa A; Takeshima T; Tsuchiya F; Iwasaki A; Matsuyama S; Hirooka N
Hinyokika Kiyo; 2012 Sep; 58(9):481-5. PubMed ID: 23070386
[TBL] [Abstract][Full Text] [Related]
3. Management of sorafenib, sunitinib, and temsirolimus toxicity in metastatic renal cell carcinoma.
Guevremont C; Alasker A; Karakiewicz PI
Curr Opin Support Palliat Care; 2009 Sep; 3(3):170-9. PubMed ID: 19528803
[TBL] [Abstract][Full Text] [Related]
4. Aortic dissection in a patient treated by sunitinib for metastatic renal cell carcinoma.
Edeline J; Laguerre B; Rolland Y; Patard JJ
Ann Oncol; 2010 Jan; 21(1):186-7. PubMed ID: 19875754
[No Abstract] [Full Text] [Related]
5. Two cases of everolimus-associated interstitial pneumonia in patients with renal cell carcinoma.
Akata K; Yatera K; Ishimoto H; Kozaki M; Yamasaki K; Nagata S; Nishida C; Yoshida T; Kawanami T; Matsumoto T; Mukae H
Intern Med; 2011; 50(24):3013-7. PubMed ID: 22185995
[TBL] [Abstract][Full Text] [Related]
6. Toxicities associated with the administration of sorafenib, sunitinib, and temsirolimus and their management in patients with metastatic renal cell carcinoma.
Bhojani N; Jeldres C; Patard JJ; Perrotte P; Suardi N; Hutterer G; Patenaude F; Oudard S; Karakiewicz PI
Eur Urol; 2008 May; 53(5):917-30. PubMed ID: 18054825
[TBL] [Abstract][Full Text] [Related]
7. Response to sorafenib after sunitinib-induced acute heart failure in a patient with metastatic renal cell carcinoma: case report and review of the literature.
Wong MK; Jarkowski A
Pharmacotherapy; 2009 Apr; 29(4):473-8. PubMed ID: 19323623
[TBL] [Abstract][Full Text] [Related]
8. Allergic interstitial nephritis possibly related to sunitinib use.
Khurana A
Am J Geriatr Pharmacother; 2007 Dec; 5(4):341-4. PubMed ID: 18179992
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of sunitinib and temsirolimus in metastatic renal cell carcinoma.
Campbell MT; Millikan RE; Altinmakas E; Xiao L; Wen SJ; Siefker-Radtke AO; Aparicio A; Corn PG; Tannir NM
Clin Genitourin Cancer; 2015 Jun; 13(3):218-24. PubMed ID: 25465491
[TBL] [Abstract][Full Text] [Related]
10. Long-term Safety of Sunitinib in Metastatic Renal Cell Carcinoma.
Porta C; Gore ME; Rini BI; Escudier B; Hariharan S; Charles LP; Yang L; DeAnnuntis L; Motzer RJ
Eur Urol; 2016 Feb; 69(2):345-51. PubMed ID: 26215605
[TBL] [Abstract][Full Text] [Related]
11. Phase I study combining treatment with temsirolimus and sunitinib malate in patients with advanced renal cell carcinoma.
Patel PH; Senico PL; Curiel RE; Motzer RJ
Clin Genitourin Cancer; 2009 Jan; 7(1):24-7. PubMed ID: 19213664
[TBL] [Abstract][Full Text] [Related]
12. Acalculous cholecystitis in a patient with metastatic renal cell carcinoma treated with sunitinib.
Gomez-Abuin G; Karam AA; Mezzadri NA; Bas CA
Clin Genitourin Cancer; 2009 Jan; 7(1):62-3. PubMed ID: 19213671
[TBL] [Abstract][Full Text] [Related]
13. Tolerability of first-line therapy for metastatic renal cell carcinoma.
Porta C; Szczylik C
Cancer Treat Rev; 2009 May; 35(3):297-307. PubMed ID: 19249157
[TBL] [Abstract][Full Text] [Related]
14. [Successful Management by Immunoglobulin for Sunitinib-Induced Thrombocytopenia in a Patient with Advanced Metastatic Renal Cell Carcinoma].
Okazaki S; Hori J; Watanabe M; Hashizume K; Kobayashi S; Azumi M; Kita M; Iwata T; Matsumoto S; Kakizaki H
Hinyokika Kiyo; 2016 Feb; 62(2):73-6. PubMed ID: 27018409
[TBL] [Abstract][Full Text] [Related]
15. Pyoderma gangrenosum with the use of sunitinib.
Nadauld LD; Miller MB; Srinivas S
J Clin Oncol; 2011 Apr; 29(10):e266-7. PubMed ID: 21220606
[No Abstract] [Full Text] [Related]
16. Patterns of interstitial lung disease during everolimus treatment in patients with metastatic renal cell carcinoma.
Mizuno R; Asano K; Mikami S; Nagata H; Kaneko G; Oya M
Jpn J Clin Oncol; 2012 May; 42(5):442-6. PubMed ID: 22438405
[TBL] [Abstract][Full Text] [Related]
17. [A case of pneumatosis cystoides intestinalis secondary to sunitinib treatment for renal cell carcinoma].
Ohtake S; Namura K; Fujikawa A; Sawada T; Ohta J; Moriyama M; Hayashi H
Hinyokika Kiyo; 2014 Feb; 60(2):75-8. PubMed ID: 24755817
[TBL] [Abstract][Full Text] [Related]
18. Biopsy-proven acute interstitial nephritis associated with the tyrosine kinase inhibitor sunitinib: a class effect?
Winn SK; Ellis S; Savage P; Sampson S; Marsh JE
Nephrol Dial Transplant; 2009 Feb; 24(2):673-5. PubMed ID: 19039026
[TBL] [Abstract][Full Text] [Related]
19. The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer.
Powles T; Blank C; Chowdhury S; Horenblas S; Peters J; Shamash J; Sarwar N; Boleti E; Sahdev A; O'Brien T; Berney D; Beltran L; Nathan P; Haanen J; Bex A
Eur Urol; 2011 Sep; 60(3):448-54. PubMed ID: 21612860
[TBL] [Abstract][Full Text] [Related]
20. Tolerance of sunitinib in dialyzed patients with metastatic renal cell carcinoma.
Vickers MM; Heng DY; Hemmelgarn B; Eigl BJ
Clin Genitourin Cancer; 2009 Oct; 7(3):E104-6. PubMed ID: 19815480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]